QuantuMDx collaboration gets $2.2M tumor profiling award; EU supports predictive preeclampsia test;

> The U.K. government-backed Biomedical Catalyst program has awarded £1.4 million ($2.2 million) to the Q-CANCER project, which includes QuantuMDx Group's rapid on‐chip lab, leading to the first sub-20-minute tumor profiler. Press release

> The EU has awarded an international consortium, which includes University College Cork, Pronota and Metabolomic Diagnostics, €6 million ($7.7 million) to bring a predictive preeclampsia test to market. Press release

> Saskatoon, Canada-based Phenomenome Discoveries has launched its colorectal cancer screening test, Cologic. Article

> A cathepsin-based blood test could predict drug responses in atherosclerosis, osteoporosis or cancer. Press release

> Empire Genomics is developing a blood DNA marker test for multiple myeloma, which will help doctors to tailor treatment. Article

And Finally… Transdermal device could monitor biomarkers in real time. Article

Suggested Articles

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.

Cybernet Manufacturing, maker of medical-grade computer monitors, has unveiled a new, large touchscreen designed to protect against infections.

A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in complications.